usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis

Survivin 96-104 (HLA-A*02:01)
( LMLGEFLKL )



LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of anti-Survivin T cell receptor (TCR) is constructed for the engineering of T cell to target Human Survivin. The T cells are genetically modified through transduction with a retroviral vector expressing Survivin-specific T cell receptor. And the vector product was designed for the treatment of diseases involving malignant cells expressing survivin.

Sequence:LMLGEFLKL
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Amount:1 mg
Counter Ion:TFA
Protein:Survivin
Species:Human
Allele:HLA-A*02:01
Application :Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication :AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1
Purity :95% HPLC-MS
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€63.50*

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Amount in mg
Product number: EP11422_1